Switch to:
More From Other Websites
Acceleron, Celgene Seek to Replace Entrenched Anti-Anemia Drugs in MDS Treatment Dec 04 2016
9:01 am Amgen and Allergan (AGN) submit biosimilar marketing... Dec 04 2016
Here's How Much Trump Tax Cuts Could Boost The Stock Market Dec 02 2016
Amgen, Regeneron 2017 LDL-Busters Could Boost This Small-Cap Biotech Dec 02 2016
Amgen Announces Launch Of Blood Counts™ And Collaboration With StoryCorps To Record And Share... Dec 02 2016
Allergan & Amgen Looking for Approvals (AGN, AMGN) Dec 02 2016
Amgen, Allergan apply for European nod for Avastin biosimilar Dec 02 2016
Amgen And Allergan Submit Biosimilar Marketing Authorization Application To European Medicines... Dec 02 2016
Bluebird Rockets On Myeloma Drug; Celgene Gets Boost Dec 01 2016
Amgen To Present At The Citi 2016 Global Healthcare Conference Dec 01 2016
Cytokinetics Gets $27M Milestone from Amgen (AMGN, CYTK) Dec 01 2016
Amgen Announces Presentation Of New Data In Acute Lymphoblastic Leukemia, Multiple Myeloma And... Dec 01 2016
The Lancet Publishes Results From COSMIC-HF Trial Showing Omecamtiv Mecarbil Significantly Improved... Dec 01 2016
The Lancet Publishes Results From COSMIC-HF Trial Showing Omecamtiv Mecarbil Significantly Improved... Dec 01 2016
Bluebird Bio, Celgene Multiple Myeloma Therapy Strong In 9-Patient Study Dec 01 2016
The Big Short’s Michael Burry Reveals His New Stock Picks Nov 30 2016
The Lancet Publishes Results From COSMIC-HF Trial Showing Omecamtiv Mecarbil Significantly Improved... Nov 30 2016
The Lancet Publishes Results From COSMIC-HF Trial Showing Omecamtiv Mecarbil Significantly Improved... Nov 30 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK